Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma

BACKGROUND Patients with T‐cell lymphomas face a poorer prognosis compared with patients with B‐cell lymphomas. New therapeutic approaches need to be developed to improve outcomes for these patients. METHODS Forty patients with recurrent and refractory T‐cell lymphomas other than mycosis fungoides a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ethan Toumishey, Angeli Prasad, Greg Dueck, Neil Chua, Daygen L. Finch, James B. Johnston, Richard van der Jagt, Doug Stewart, Darrell White, Andrew R. Belch, Tony Reiman
Format: Artigo
Sprache:Englisch
Veröffentlicht: 2014
Online-Zugang:https://doi.org/10.1002/cncr.29103
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29103
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!